4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001209191-20-048883
Chief Financial Officer sold 509 shares at $22.82 ($11,615)
- Chief Financial Officer acquired 1,042 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PFREUNDSCHUH PETER P. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-01 | Exercise or conversion : show line 1 in the form | +1,042 | 8,397 | D | ||
| 2020-09-01 | Sale : show line 2 in the form | −509 | $22.82 | $11,615 | 7,888 | D |
| Open-market sales · 509 sh · avg $22.82 · $11,615 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-09-01 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,042 | 1,042 | 4,166 | D |
Loading xslF345X03/doc4.xml…